20-38131150-C-T
Variant summary
Our verdict is Likely benign. The variant received -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_004613.4(TGM2):c.1856G>A(p.Gly619Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000428 in 1,613,676 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 17/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_004613.4 missense
Scores
Clinical Significance
Conservation
Publications
- type 2 diabetes mellitusInheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -6 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000329 AC: 5AN: 152116Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000120 AC: 3AN: 250784 AF XY: 0.0000148 show subpopulations
GnomAD4 exome AF: 0.0000438 AC: 64AN: 1461560Hom.: 0 Cov.: 31 AF XY: 0.0000426 AC XY: 31AN XY: 727092 show subpopulations
GnomAD4 genome AF: 0.0000329 AC: 5AN: 152116Hom.: 0 Cov.: 32 AF XY: 0.0000404 AC XY: 3AN XY: 74294 show subpopulations
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.1856G>A (p.G619D) alteration is located in exon 12 (coding exon 12) of the TGM2 gene. This alteration results from a G to A substitution at nucleotide position 1856, causing the glycine (G) at amino acid position 619 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at